N. Lanir

1.3k total citations
24 papers, 1.0k citations indexed

About

N. Lanir is a scholar working on Hematology, Rheumatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, N. Lanir has authored 24 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 8 papers in Rheumatology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in N. Lanir's work include Blood Coagulation and Thrombosis Mechanisms (10 papers), Systemic Lupus Erythematosus Research (7 papers) and Blood properties and coagulation (5 papers). N. Lanir is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (10 papers), Systemic Lupus Erythematosus Research (7 papers) and Blood properties and coagulation (5 papers). N. Lanir collaborates with scholars based in Israel, United States and United Kingdom. N. Lanir's co-authors include Ann M. Dvořàk, J McDonagh, Harold F. Dvorak, Benjamin Brenner, Benjamin Brenner, Zeev Blumenfeld, Zeev Weiner, Lawrence F. Brown, K Tognazzi and Galit Sarig and has published in prestigious journals such as Blood, The Journal of Immunology and Acta Biomaterialia.

In The Last Decade

N. Lanir

24 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Lanir Israel 16 627 181 174 173 167 24 1.0k
Ariela Hoxha Italy 24 716 1.1× 70 0.4× 129 0.7× 51 0.3× 108 0.6× 85 1.5k
Elena Pontara Italy 22 1.2k 1.9× 110 0.6× 217 1.2× 100 0.6× 10 0.1× 85 1.6k
L Stockx Belgium 24 66 0.1× 264 1.5× 269 1.5× 877 5.1× 130 0.8× 82 1.9k
Alina D. Peshkova United States 17 468 0.7× 253 1.4× 127 0.7× 478 2.8× 8 0.0× 40 983
Nicolas Gendron France 15 84 0.1× 107 0.6× 99 0.6× 114 0.7× 19 0.1× 81 659
Richard A. Freiberg United States 22 307 0.5× 156 0.9× 85 0.5× 89 0.5× 18 0.1× 45 2.0k
Mark Cobby United Kingdom 15 405 0.6× 22 0.1× 47 0.3× 60 0.3× 50 0.3× 29 1.7k
Anne Demulder Belgium 17 308 0.5× 39 0.2× 24 0.1× 82 0.5× 9 0.1× 52 1.2k
F Fantini Italy 23 767 1.2× 25 0.1× 43 0.2× 128 0.7× 11 0.1× 69 1.6k
Mary‐Carmen Amigo Mexico 23 605 1.0× 25 0.1× 141 0.8× 212 1.2× 23 0.1× 50 1.6k

Countries citing papers authored by N. Lanir

Since Specialization
Citations

This map shows the geographic impact of N. Lanir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Lanir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Lanir more than expected).

Fields of papers citing papers by N. Lanir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Lanir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Lanir. The network helps show where N. Lanir may publish in the future.

Co-authorship network of co-authors of N. Lanir

This figure shows the co-authorship network connecting the top 25 collaborators of N. Lanir. A scholar is included among the top collaborators of N. Lanir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Lanir. N. Lanir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tzchori, Itai, N. Lanir, Mizied Falah, et al.. (2014). The formation of an anti-restenotic/anti-thrombotic surface by immobilization of nitric oxide synthase on a metallic carrier. Acta Biomaterialia. 10(5). 2304–2312. 17 indexed citations
2.
Avivi, Irit, et al.. (2002). Hyperhomocysteinemia is common in patients with antiphospholipid syndrome and may contribute to expression of major thrombotic events. Blood Coagulation & Fibrinolysis. 13(2). 169–172. 18 indexed citations
3.
Elhasid, Ronit, N. Lanir, Rivka Sharon, et al.. (2001). Prophylactic therapy with enoxaparin during l-asparaginase treatment in children with acute lymphoblastic leukemia. Blood Coagulation & Fibrinolysis. 12(5). 367–370. 92 indexed citations
4.
McVey, John H., Edward G. D. Tuddenham, Andrew Mumford, et al.. (2000). Molecular analysis of the genotype-phenotype relationship in factor VII deficiency. Human Genetics. 107(4). 327–342. 76 indexed citations
5.
Ohel, G., et al.. (1999). High prevalence of activated protein C resistance due to factor V leiden mutation in cases of intrauterine fetal death. The Journal of Maternal-Fetal Medicine. 8(5). 228–230. 9 indexed citations
6.
7.
Lanir, N., et al.. (1998). Reactivity patterns of antiphosphilipid antibodies and endothelial cells: Effect of antiendothelial antibodies on cell migration. Journal of Laboratory and Clinical Medicine. 131(6). 548–556. 19 indexed citations
8.
Bergman, Richard N., et al.. (1997). A study of coagulation and anti-endothelial antibodies in idiopathic livedo reticularis.. Acta Dermato Venereologica. 77(3). 181–183. 3 indexed citations
9.
Scharf, J., et al.. (1997). Retinal Arterial Occlusion in a Child With Factor V Leiden and Thermolabile Methylene Tetrahydrofolate Reductase Mutations. American Journal of Ophthalmology. 124(5). 689–691. 27 indexed citations
10.
Brenner, Benjamin, et al.. (1997). Bleeding predictors in factor-XI-deficient patients. Blood Coagulation & Fibrinolysis. 8(8). 511–516. 40 indexed citations
11.
Berant, Moshe, R Brik, Ayelet Ben‐Barak, N. Lanir, & P J Milla. (1997). ANTIPHOSPHATIDYL CHOLINE ANTIBODIES (aPC) ASSOCIATED WITH INTRAVENOUS FAT INFUSIONS: THE ROLE OF AUTOIMMUNITY. Journal of Pediatric Gastroenterology and Nutrition. 24(4). 462–462. 1 indexed citations
12.
Brenner, Benjamin, et al.. (1996). Coexistence of familial antiphospholipid syndrome and factor V Leiden: impact on thrombotic diathesis. British Journal of Haematology. 94(1). 166–167. 38 indexed citations
13.
14.
Blank, Miri, Ilan Krause, N. Lanir, et al.. (1995). Transfer of experimental antiphospholipid syndrome by bone marrow cell transplantation the importance of the t cell. Arthritis & Rheumatism. 38(1). 115–122. 36 indexed citations
15.
Pery, Menucha, N. Lanir, A. L. Markel, et al.. (1995). Application of a bedside whole blood D-dimer assay in the diagnosis of deep vein thrombosis. Blood Coagulation & Fibrinolysis. 6(3). 219–222. 35 indexed citations
16.
Wolfovitz, Efrat, Michael Aviram, J.G. Brook, I. Tatarsky, & N. Lanir. (1995). Protective Effect of Low Concentrations of Oxidized Low-Density Lipoprotein on Endothelial Cell Integrity. European Journal of Cardiovascular Prevention & Rehabilitation. 2(1). 57–62. 3 indexed citations
17.
Miller, Ariel, N. Lanir, Michel Revel, et al.. (1994). Immunoregulatory effects of recombinant human interferon-β (IFN-β) on human microvessel endothelial cells interactions with IFN-γ. Journal of Neuroimmunology. 54(1-2). 182–182. 1 indexed citations
18.
Nitecki, Samy, Benjamin Brenner, Aaron Hoffman, et al.. (1993). Lower limb ischaemia in primary antiphospholipid syndrome. European Journal of Vascular Surgery. 7(4). 414–419. 21 indexed citations
19.
Lanir, N., Benjamin Brenner, & I. Tatarsky. (1992). Abnormalities of fibrinolytic parameters in patients with myeloproliferative diseases. Fibrinolysis and Proteolysis. 6(3). 183–186. 2 indexed citations
20.
Lanir, N., et al.. (1988). Macrophage migration in fibrin gel matrices. II. Effects of clotting factor XIII, fibronectin, and glycosaminoglycan content on cell migration.. The Journal of Immunology. 140(7). 2340–2349. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ariela Hoxha Breakdown of academic impact, for papers by Elena Pontara Breakdown of academic impact, for papers by L Stockx Breakdown of academic impact, for papers by Alina D. Peshkova Breakdown of academic impact, for papers by Nicolas Gendron Breakdown of academic impact, for papers by Richard A. Freiberg Breakdown of academic impact, for papers by Mark Cobby Breakdown of academic impact, for papers by Anne Demulder Breakdown of academic impact, for papers by F Fantini Breakdown of academic impact, for papers by Mary‐Carmen Amigo
Rankless by CCL
2026